Our site uses cookies to make navigation as functional as possible, including "third party" cookies and "profiling cookies" designed to tailor on-line contents to suit the preferences expressed while surfing the internet. Should you wish to receive more information, or deny your consent to some or all cookies, click here. If you proceed browsing this website, you will be consenting to the use of all cookies.

News

Press Release
Page Available only in italian language
Press Release
Page Available only in italian language
Press Release
Page available only in italian language 
Press Release
Press Release
Page available only in italian language
The Menarini Group announces meropenem/vaborbactam European marketing authorization
Meropenem/vaborbactam approved on 20th November 2018 by the European Commission for clinical use in adult patients with difficult-to-treat infections. The first combination of a carbapenem and a beta-lactamase inhibitor...
Page 4 of 5First   Previous   1  2  3  [4]  5  Next   Last   

MENARINI PILLS OF ART

Concession granted by Italian Ministry for Cultural Heritage and Activities Read more